Skip to main content

Table 2 Crude and adjusted analysis of the association between sleep duration and cardiometabolic risk factors in adolescents. São Luís, Maranhão, Brazil, 2016/2017

From: Association between sleep duration and cardiometabolic factors in adolescents

Variables Crude analysis Adjusted analysis  
β (95%IC) p β (95%IC) p
Glycemia (mg/dL)
 Sleep duration   0.407   0.760
  ≥ 6 h 0   0a  
  < 6 h 0.82(-1.11;2.75)   0.33(-1.80;2.47)  
SBP (mmHg)
 Sleep duration   0.001   0.910
  ≥ 6 h 0   0b  
  < 6 h 2.90(1.43;4.37)   -0.08(-1.50;1.34)  
DBP (mmHg)
 Sleep duration   0.202   0.898
  ≥ 6 h 0   0b  
  < 6 h 0.58(-0.31;1.48)   0.06(-0.92;1.05)  
HDL-c (mg/dL)
 Sleep duration   0.145   0.286
  ≥ 6 h 0   0a  
  < 6 h -1.04(-2.44;0.36)   0.93(-0.78;2.63)  
LDL-c (mg/dL)
 Sleep duration   0.036   0.303
  ≥ 6 h 0   0a  
  < 6 h -3.33(-6.45;-0.22)   -1.90(-5.51;1.71)  
Total cholesterol (mg/dL)
 Sleep duration   0.098   0.941
  ≥ 6 h 0   0a  
  < 6 h -3.18(-6.94;0.59)   -0.16(-4.55;4.22)  
Triglycerides (mg/dL)
 Sleep duration   0.308   0.969
  ≥ 6 h 0   0a  
  < 6 h 2.98(-2.75;8.71)   0.13(-6.36;6.62)  
  1. 95%IC 95% confidence interval; DBP Diastolic blood pressure; SBP systolic blood pressure; LDL-c low-density lipoprotein cholesterol; HDL-c high density lipoprotein cholesterol. aModel 1 = Adjusted for age, gender, adolescent years of study, skin color, economic class, current work, alcohol consumption, smoking, physical activity, screen time, food consumption; bModel 2 = Adjusted Model 1 + depression